We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$12.3B
AUM Growth
+$1.06B
Cap. Flow
+$761M
Cap. Flow %
6.18%
Top 10 Hldgs %
58.32%
Holding
100
New
18
Increased
36
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$896M
2
COL
Rockwell Collins
COL
+$339M
3
MON
Monsanto Co
MON
+$161M
4
ELV icon
Elevance Health
ELV
+$131M
5
CHTR icon
Charter Communications
CHTR
+$92.5M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$508M
2
TWX
Time Warner Inc
TWX
+$393M
3
HDS
HD Supply Holdings, Inc.
HDS
+$196M
4
KITE
Kite Pharma, Inc.
KITE
+$175M
5
ALR
Alere Inc
ALR
+$138M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 15.61%
3 Communication Services 13.96%
4 Financials 11.79%
5 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
76
KALA BIO
KALA
$15.9M
$3.42M 0.03%
74
+34
+85% +$1.59M
SNI
77
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$3.42M 0.03%
40,000
-195,000
-83% -$16.1M
BKD icon
78
Brookdale Senior Living
BKD
$2.82B
$3.2M 0.03%
330,000
– –
BMS
79
DELISTED
Bemis
BMS
$2.87M 0.02%
+60,000
New +$2.77M
GCVRZ
80
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.6M 0.02%
6,827,805
– –
CYOU
81
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$2.55M 0.02%
70,000
-170,000
-71% -$6.42M
CLLS
82
Cellectis
CLLS
$342M
– –
-385,000
Closed -$11M
CMCSA icon
83
Comcast
CMCSA
$95.3B
– –
-1,741,621
Closed -$67M
EXEL icon
84
Exelixis
EXEL
$13.4B
– –
-1,190,000
Closed -$28.8M
GILD icon
85
Gilead Sciences
GILD
$181B
– –
-945,000
Closed -$76.6M
HLF icon
86
Herbalife
HLF
$1.33B
– –
-2,519,670
Closed -$85.5M
RGNX icon
87
Regenxbio
RGNX
$708M
– –
-417,000
Closed -$13.7M
RYAAY icon
88
Ryanair
RYAAY
$28.9B
– –
-488,455
Closed -$20.6M
SBAC icon
89
SBA Communications
SBAC
$19.4B
– –
-136,738
Closed -$19.7M
STZ icon
90
Constellation Brands
STZ
$23.2B
– –
-654,869
Closed -$131M
DCPH
91
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-100,000
Closed -$1.9M
HDS
92
DELISTED
HD Supply Holdings, Inc.
HDS
– –
-5,434,168
Closed -$196M
STML
93
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-1,187,500
Closed -$13.2M
NITE
94
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
– –
-40,300
Closed -$774K
BRCD
95
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
– –
-5,130,000
Closed -$61.3M
KITE
96
DELISTED
Kite Pharma, Inc.
KITE
– –
-974,435
Closed -$175M
ALR
97
DELISTED
Alere Inc
ALR
– –
-2,700,000
Closed -$138M
PCO
98
DELISTED
Pendrell Corporation - Class A
PCO
– –
-8,211
Closed -$5.61M
ESV
99
DELISTED
Ensco Rowan plc
ESV
– –
-1,230,000
Closed -$29.4M
BCR
100
DELISTED
CR Bard Inc.
BCR
– –
-1,585,000
Closed -$508M
1 2 3
4

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2017 Portfolio in Review

As of Q4 2017, Thomas Steyer held 100 positions worth $12.3B, up 9.4% from $11.3B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Thomas Steyer deployed $761M of net new capital in Q4 2017, opening 18 new positions and adding to 36 existing holdings. Its largest new stake was Aetna Inc: 5,215,000 shares worth $941M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Time Warner Inc, an estimated $393M trimmed.

  • Thomas Steyer's largest Q4 2017 buy was Aetna Inc: 5,215,000 shares worth $941M.
  • Thomas Steyer added most to Monsanto Co in Q4 2017, an estimated $161M increase.
  • Thomas Steyer's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $393M.
  • Thomas Steyer fully exited CR Bard Inc. in Q4 2017, selling an estimated $508M.
  • Thomas Steyer's ten largest holdings make up 58% of its $12.3B portfolio in Q4 2017.
  • Thomas Steyer opened 18 new positions and closed 19 in Q4 2017.
  • Thomas Steyer's portfolio value rose 9.4% quarter-over-quarter to $12.3B.

Based on Farallon Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.